2-((2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate

Catalog No. :
ACPTGT278
CAS No. :
124832-26-4
Molecular Formula :
C13H20N6O4
Molecular Weight :
324.34

IUPAC Name:Valacyclovir

2-((2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$95.00Login to see priceInquiryInquiry
10mg98%$156.00Login to see priceInquiryInquiry
25mg98%$283.00Login to see priceInquiryInquiry
50mg98%$458.00Login to see priceInquiryInquiry
100mg98%$728.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate
IUPAC NameValacyclovir
Molecular FormulaC13H20N6O4
Molecular Weight324.34
SMILESN[C@@H](C(C)C)C(OCCOCN1C=NC2=C1N=C(N)NC2=O)=O
InChI KeyHDOVUKNUBWVHOX-QMMMGPOBSA-N
SynonymValaciclovir & Valaciclovir Hydrochloride;Valacyclovir-d4;L-VALINE 2-[(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9YL)METHOXY]ETHYL ESTER;L-VALINE 2-[(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9YL)METHOXY]ETHYL ESTER, HYDROCHLORIDE SALT;l-valine 2-(guanin-9-ylmethoxy)ethyl ester;VALACICLOVIR;VALACICLOVIR HCL;VALACICLOVIR HYDROCHLORIDE
CAS No.124832-26-4

Synthetic Route by SureRoute

1. ACPTGT278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJCBD430 route compound structure diagram
    ACJCBD430124832-31-1 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACPTGT278 route product structure diagram
    ACPTGT278124832-26-4
Inquiry

2. ACPTGT278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPTGT278 route product structure diagram
    ACPTGT278124832-26-4
Inquiry

Comments (0)